Literature DB >> 11393261

The role of chemotherapy and prophylactic bilateral oophorectomy in a case of colorectal adenocarcinoma with ovarian metastases.

E K Shin1, B T Takizawa, L Masters, S Shahabi.   

Abstract

A 66-year-old female presented with a large abdominal mass and accompanying systemic complaints of abdominal pain, constipation. and fever. On exploratory laparotomy, the mass was found to be a moderately differentiated adenocarcinoma of the sigmoid colon with metastasis to the left ovary. A primary colorectal carcinoma that has metastasized to the ovaries can be difficult to distinguish clinically from an advanced primary ovarian tumor. Histology and tumor markers are currently the most useful tools available in making an accurate diagnosis. If the nature of the primary tumor is uncertain and the initial response to chemotherapy is poor, the patient's prognosis will also he poor. Though controversy exists regarding the role of prophylactic bilateral oophorectomy during resection for primary colorectal cancer, later confusion can be avoided by performing this procedure when the colorectal carcinoma is first diagnosed. However the possibility of a concurrent primary ovarian tumor must not be overlooked.

Entities:  

Mesh:

Year:  2001        PMID: 11393261      PMCID: PMC2588692     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  21 in total

1.  Long-term survival in patients with ovarian metastases from colorectal carcinoma.

Authors:  P P Huang; T K Weber; C Mendoza; M A Rodriguez-Bigas; N J Petrelli
Journal:  Ann Surg Oncol       Date:  1998-12       Impact factor: 5.344

2.  Prophylactic oophorectomy in colorectal carcinoma: preliminary results of a randomized, prospective trial.

Authors:  T M Young-Fadok; B G Wolff; S Nivatvongs; P P Metzger; D M Ilstrup
Journal:  Dis Colon Rectum       Date:  1998-03       Impact factor: 4.585

Review 3.  [Primary and secondary ovarian tumors in patients with colorectal carcinoma. Thoughts on preventive oophorectomy].

Authors:  E Bedó
Journal:  Orv Hetil       Date:  1996-10-13       Impact factor: 0.540

4.  Ovarian and uterine disease in women with colorectal cancer.

Authors:  N Abu-Rustum; R R Barakat; J P Curtin
Journal:  Obstet Gynecol       Date:  1997-01       Impact factor: 7.661

5.  Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy.

Authors:  K Sengoku; T Satoh; S Saitoh; M Abe; M Ishikawa
Journal:  Int J Gynaecol Obstet       Date:  1994-07       Impact factor: 3.561

6.  Ovarian metastasis in patients with colorectal carcinoma.

Authors:  J A Perdomo; A Hizuta; H Iwagaki; S Takasu; Y Nonaka; T Kimura; S Takada; L F Moreira; N Tanaka; K Orita
Journal:  Acta Med Okayama       Date:  1994-02       Impact factor: 0.892

7.  Clinical implications of metastases to the ovary.

Authors:  K Fujiwara; Y Ohishi; H Koike; S Sawada; T Moriya; I Kohno
Journal:  Gynecol Oncol       Date:  1995-10       Impact factor: 5.482

8.  Simultaneous bilateral oophorectomy does not improve prognosis of postmenopausal women undergoing colorectal resection for cancer.

Authors:  I Sielezneff; E Salle; K Antoine; X Thirion; C Brunet; B Sastre
Journal:  Dis Colon Rectum       Date:  1997-11       Impact factor: 4.585

9.  Malignant tumors metastatic to the ovaries.

Authors:  A Ayhan; Z S Tuncer; O Bükülmez
Journal:  J Surg Oncol       Date:  1995-12       Impact factor: 3.454

10.  Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.

Authors:  U Hasholzner; L Baumgartner; P Stieber; W Meier; K Hofmann; A Fateh-Moghadam
Journal:  Anticancer Res       Date:  1994 Nov-Dec       Impact factor: 2.480

View more
  1 in total

1.  Multiple metastases of soft tissue visualized by technetium-99m-methylene diphosphonate scintigraphy: a case report.

Authors:  Mauro Liberatore; Valentina Megna; Gregorio Patrizi; Domenico Giannotti; Camilla Proietti Semproni; Stefania Rebonato; Flavio Barchetti; Pietro Gallo; Giandomenico Miscusi
Journal:  J Med Case Rep       Date:  2014-12-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.